报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 0.51% | 920% | -3.77% | 101/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 0.53% | -78.01% | 26.19% | 91/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.42% | -62.16% | -84.27% | 91/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 2.67% | -58.41% | 5240% | 86/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 0.05% | -99.44% | -97.93% | 109/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 2.41% | -36.91% | 117.12% | 71/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 1.11% | -41.58% | -82.71% | 80/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 6.42% | -62.19% | -28.67% | 84/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 9% | 2% | 135.6% | 58/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 3.82% | -36.33% | 101.05% | 78/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 1.9% | 2% | -88.81% | 71/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 16.98% | -27.62% | 183% | 51/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-06-30 | 6% | -62.62% | -74.42% | 71/129 | 11.54% | 热景生物 | 99.69% | 行业排名> |
2020-12-31 | 23.46% | 5.58% | 46.17% | 42/129 | 25.82% | 热景生物 | 99.09% | 行业排名> |
2020-06-30 | 16.05% | 2% | -27.77% | 28/129 | 15.16% | 热景生物 | 57.63% | 行业排名> |
2019-12-31 | 22.22% | 30.32% | 30.32% | 34/129 | 14.38% | 中红医疗 | 168% | 行业排名> |
2018-12-31 | 17.05% | -39.82% | -39.82% | 43/129 | 12.98% | 圣湘生物 | 112.46% | 行业排名> |
2017-12-31 | 28.33% | -32.26% | -32.26% | 18/129 | 13.82% | 博拓生物 | 108.13% | 行业排名> |
2016-12-31 | 41.82% | 2% | 2% | 2/129 | 16.21% | 圣湘生物 | 29.33% | 行业排名> |